These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

41 related articles for article (PubMed ID: 2111904)

  • 1. [Therapeutic use of a gonadotropin releasing hormone analogue in breast cancer].
    Kahán Z; Falkay G
    Orv Hetil; 1990 May; 131(19):1033-6. PubMed ID: 2111904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of breast cancer with gonadotropin-releasing hormone.
    Manni A; Santen R; Harvey H; Lipton A; Max D
    Endocr Rev; 1986 Feb; 7(1):89-94. PubMed ID: 3082618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pituitary gonadotropin releasing hormone (GnRH) and breast cancer].
    Vargas Hernández VM; Moctezuma Espinosa J
    Ginecol Obstet Mex; 1995 Dec; 63():493-6. PubMed ID: 8586292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gonadotropin-releasing hormone analogues added to adjuvant chemotherapy protect ovarian function and improve clinical outcomes in young women with early breast carcinoma.
    Recchia F; Saggio G; Amiconi G; Di Blasio A; Cesta A; Candeloro G; Rea S
    Cancer; 2006 Feb; 106(3):514-23. PubMed ID: 16388519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Induction of ovulation and pregnancy resulting from chronic and pulsatile administration of gonadotropin-releasing-hormone (Gn-RH)].
    Ropert JF; Gaillard G; Doly M; Bruhat MA
    J Gynecol Obstet Biol Reprod (Paris); 1982; 11(4):505-8. PubMed ID: 6815258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.
    Celio L; Martinetti A; Ferrari L; Buzzoni R; Mariani L; Miceli R; Seregni E; Procopio G; Cassata A; Bombardieri E; Bajetta E
    Anticancer Res; 1999; 19(3B):2261-8. PubMed ID: 10472341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complete estrogen blockade with buserelin and aminoglutethimide for advanced breast cancer: a phase I-II study with long-term hormonal correlations.
    Ferrari V; Zaniboni A; Simoncini E; Marpicati E; Montini E; Moretti R; Marini G
    Chemioterapia; 1988 Dec; 7(6):414-9. PubMed ID: 3146444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
    El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
    Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic uses of gonadotropin-releasing hormone analogs.
    Andreyko JL; Marshall LA; Dumesic DA; Jaffe RB
    Obstet Gynecol Surv; 1987 Jan; 42(1):1-21. PubMed ID: 3543765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of endometriosis with gonadotropin releasing hormone agonist (buserelin).
    Sirimongkolkasem R; Rojanasakul A; Chailurkit LO
    J Med Assoc Thai; 1990 Feb; 73 Suppl 1():37-41. PubMed ID: 2112582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LHRH-analogues: clinical results in ovarian and breast cancer].
    Sismondi P; Giai M; Defabiani E; Cortese P
    Minerva Ginecol; 1990 Jun; 42(6):227-37. PubMed ID: 2199855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The efficacy of every-other-day administration of gonadotropin-releasing hormone in women with hypothalamic amenorrhea: gonadotropin-releasing hormone treatment can induce clomiphene responsiveness.
    Kotsuji F; Aso T; Kamitani N; Tominaga T; Kitaguchi M; Okamura Y
    Obstet Gynecol; 1988 Apr; 71(4):615-21. PubMed ID: 3281077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GnRH analogues in the treatment of endometriosis.
    Erickson LD; Ory SJ
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term endocrine profiles of prostatic carcinoma patients under pernasal as well as intramuscular Gn-RH analogue treatment.
    Wenderoth UK; Jacobi GH
    Prog Clin Biol Res; 1985; 185A():297-305. PubMed ID: 3162176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of premenopausal patients with advanced or recurrent breast cancer by chemical ablation].
    Sun Q; Huang HY; Zhou YD; Mao F; Yang YQ; Xing Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2003 Feb; 25(1):60-2. PubMed ID: 12905610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gonadotropin releasing hormone agonists. A new therapeutic principle in gynecology].
    Tanbo T; Henriksen T; Magnus O; Abyholm T
    Tidsskr Nor Laegeforen; 1988 Jan; 108(2):132-5. PubMed ID: 2965433
    [No Abstract]   [Full Text] [Related]  

  • 17. The treatment of postmenopausal women with advanced breast cancer with buserelin.
    Waxman JH; Harland SJ; Coombes RC; Wrigley PF; Malpas JS; Powles T; Lister TA
    Cancer Chemother Pharmacol; 1985; 15(2):171-3. PubMed ID: 3926333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of chemotherapy to hormonal levels in postmenopausal breast cancer patients.
    Pribylova O; Springer D; Svobodnik A; Kyr M; Zima T; Petruzelka L
    Neoplasma; 2008; 55(4):294-8. PubMed ID: 18505339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gonadotrophin-releasing hormone agonists for new approaches to contraception in man.
    Nillius SJ
    Wien Klin Wochenschr; 1985 Dec; 97(23):865-73. PubMed ID: 3934848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous estrogen, androgen, and progesterone concentrations and breast cancer risk among postmenopausal women.
    Missmer SA; Eliassen AH; Barbieri RL; Hankinson SE
    J Natl Cancer Inst; 2004 Dec; 96(24):1856-65. PubMed ID: 15601642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.